← Open Payments lookup

ALMA MANLANGIT: Open Payments

NPI 1316345788 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$348 in 11 payments from 8 companies in 2025. Trend: 2023 $24 · 2024 $0 · 2025 $348

Food & beverage: $348
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$129
AstraZeneca Pharmaceuticals LP2$46
Bayer Healthcare Pharmaceuticals Inc.2$38
Kowa Pharmaceuticals America, Inc.2$36
Edwards Lifesciences Corporation1$35
Astellas Pharma US Inc1$22
Dexcom, Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: INGREZZA, Kerendia, ZORYVE, FARXIGA, Veozah, Dexcom G6 Transmitter, CAPLYTA, BREZTRI.

Industry payments across NV — which companies pay providers there.